Tevogen Stock Surges on Expanded Microsoft AI Collaboration

Seeking Alpha

01/25

Tevogen Bio (NASDAQ:TVGN) stock jumped nearly 26% post-market after the company announced it has expanded its relationship with Microsoft (NASDAQ:MSFT) to broaden their AI-focused collaboration and build its PredicTcell technology for predictive precision T cell targeting.

The Tevogen.AI initiative will integrate Microsoft's AI tools and Azure cloud platform to expand Tevogen's (NASDAQ:TVGN) ExacTcell preclinical pipeline. The initiative will also aim to develop proprietary algorithms to decode HLA-T cell interactions, according to a statement.

The company added it is also investigating potential treatments for HPV and identifying cytotoxic T cell targets to select for a clinical trial for its first oncology drug candidate, TVGN 920.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1132878034"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1132878034\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1132878034?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-25 11:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1132878034","market":"us","top_or_hot":-1,"title":"Tevogen Stock Surges on Expanded Microsoft AI Collaboration","media":"Seeking Alpha","content":"<html><head></head><body><p>Tevogen Bio (NASDAQ:TVGN) stock jumped nearly 26% post-market after the company announced it has expanded its relationship with Microsoft (NASDAQ:MSFT) to broaden their AI-focused collaboration and build its PredicTcell technology for predictive precision T cell targeting.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/7aa6cab6471e2c39405d9d453c079811\" tg-width=\"883\" tg-height=\"622\"/></p><p style=\"text-align: left;\">The Tevogen.AI initiative will integrate Microsoft&#39;s AI tools and Azure cloud platform to expand Tevogen&#39;s (NASDAQ:TVGN) ExacTcell preclinical pipeline. The initiative will also aim to develop proprietary algorithms to decode HLA-T cell interactions, according to a statement.</p><p style=\"text-align: left;\">The company added it is also investigating potential treatments for HPV and identifying cytotoxic T cell targets to select for a clinical trial for its first oncology drug candidate, TVGN 920.</p></body></html>","source":"lsy1728464409321","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tevogen Stock Surges on Expanded Microsoft AI Collaboration</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTevogen Stock Surges on Expanded Microsoft AI Collaboration\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Seeking Alpha</strong><span class=\"h-time small\">2025-01-25 11:15</span>\n</p>\n</h4>\n</header>\n<article>\n<html><head></head><body><p>Tevogen Bio (NASDAQ:TVGN) stock jumped nearly 26% post-market after the company announced it has expanded its relationship with Microsoft (NASDAQ:MSFT) to broaden their AI-focused collaboration and build its PredicTcell technology for predictive precision T cell targeting.</p><p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/7aa6cab6471e2c39405d9d453c079811\" tg-width=\"883\" tg-height=\"622\"/></p><p style=\"text-align: left;\">The Tevogen.AI initiative will integrate Microsoft&#39;s AI tools and Azure cloud platform to expand Tevogen&#39;s (NASDAQ:TVGN) ExacTcell preclinical pipeline. The initiative will also aim to develop proprietary algorithms to decode HLA-T cell interactions, according to a statement.</p><p style=\"text-align: left;\">The company added it is also investigating potential treatments for HPV and identifying cytotoxic T cell targets to select for a clinical trial for its first oncology drug candidate, TVGN 920.</p></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://seekingalpha.com/news/4398655-tevogen-stock-rallies-on-expanded-microsoft-ai-collaboration\">Seeking Alpha</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TVGN","symbol_name":"Tevogen Bio Holdings","start_time":0,"source_url":"https://seekingalpha.com/news/4398655-tevogen-stock-rallies-on-expanded-microsoft-ai-collaboration","article_id":"1132878034","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1132878034","pubTimestamp":1737774900,"columns":[],"sourceInfo":{"source_id":"lsy1728464409321","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Tevogen Bio  stock jumped nearly 26% post-market after the company announced it has expanded its relationship with Microsoft  to broaden their AI-focused collaboration and build its PredicTcell technology for predictive precision T cell targeting.The Tevogen.AI initiative will integrate Microsoft's AI tools and Azure cloud platform to expand Tevogen's  ExacTcell preclinical pipeline. The initiative will also aim to develop proprietary algorithms to decode HLA-T cell interactions, according to a ","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TVGN":"Tevogen Bio Holdings","MSFT":"微软"},"translate_title":"Tevogen股价因微软人工智能合作扩大而飙升","themeId":"3438f2c5d0af3ac7098ae251e297d7d5","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MSFT":1.1,"TVGN":1.1},"content_text":"Tevogen Bio (NASDAQ:TVGN) stock jumped nearly 26% post-market after the company announced it has expanded its relationship with Microsoft (NASDAQ:MSFT) to broaden their AI-focused collaboration and build its PredicTcell technology for predictive precision T cell targeting.The Tevogen.AI initiative will integrate Microsoft's AI tools and Azure cloud platform to expand Tevogen's (NASDAQ:TVGN) ExacTcell preclinical pipeline. The initiative will also aim to develop proprietary algorithms to decode HLA-T cell interactions, according to a statement.The company added it is also investigating potential treatments for HPV and identifying cytotoxic T cell targets to select for a clinical trial for its first oncology drug candidate, TVGN 920.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}